Register for the Versalus Health Resource Center to view the recording of this and previous Versalus Health's webinars. To register, visit: www.versalushealth.com/resources/
The Centers for Medicare and Medicaid Services (CMS) released CY2021 OPPS in late December. As usual, there are several issues on the final rule that are causing confusion. One of the most intensely debated changes is the phased elimination of the Inpatient Only List (IPO).
During this webinar, Versalus Health regulatory experts will discuss the implications of the phasing out of the Inpatient Only list and some of the most meaningful changes included in the final rule.
Join this webinar to learn:
- What are the implications of the IPO list elimination for your organization:
- How this change impacts admission status decisions
- What is the financial impact of the elimination of the IPO list
- What the operational changes required to comply with this change
- What you need to know regarding the ASC List Updates, 340B acquired drugs payment methodology, and new procedures requiring authorization
- Date: Wednesday, January 20, 2021
- Time: 2:00 pm ET | 11:00 am PT
- Duration: 60 minutes
Questions? Call us: 484.766.1625 or Email us: firstname.lastname@example.org
Meet the Speakers
Robert R. Corrato, MD, MBA
Chief Executive Officer
Dr. Robert R. Corrato is Founder and Chief Executive Officer of Versalus Health. Before Versalus, Dr. Corrato was Founder and Managing Partner of Devon Hill Capital Partners (DHCP), a diversified healthcare investment firm. Prior to founding DHCP, Dr. Corrato was the Founder, Chairman and President & CEO of Executive Health Resources (EHR). In his roles at EHR, Dr. Corrato was responsible for driving the vision and strategy for corporate growth to best serve the healthcare compliance industry, growing EHR into the leading national provider of medical necessity compliance solutions that served the needs of over 2,000 hospitals, performed concurrent reviews on millions of Medicare short-stay cases, overturned thousands of Medicare denials and successfully defended scores of hospitals under investigation by the Office of the Inspector General (OIG) and Department of Justice (DOJ). Prior to founding EHR, Dr. Corrato held the post of deputy director of the Office of Health Policy and Clinical Outcomes at Thomas Jefferson University in Philadelphia.
Dr. Corrato earned his master of business administration degree from the Wharton School of Business at the University of Pennsylvania and received his medical degree from the Medical College of Pennsylvania.
Thomas McCarter, MD, FACP, FCPP
Executive Vice President & Chief Medical Officer
Dr. Thomas McCarter serves as Executive Vice President and Chief Medical Officer at Versalus Health. Prior to joining Versalus, Dr. McCarter was Chief Clinical Officer of Executive Health Resources (EHR) where he was responsible for clinical research, physician education, regulatory policy and the rules used to adjudicate over 10 million medical necessity reviews for over 2,000 hospitals across the United States to achieve Medicare regulatory compliance and clinical appropriateness.
Dr. McCarter has served as Senior Vice President of Medical Affairs and Chief Medical Officer of Main Line Health System in Philadelphia, and as Vice President of Medical Affairs for Tenet Health System’s Pennsylvania Region. He served faculty positions at the University of Pennsylvania, Hahnemann University, Medical College of Pennsylvania, Geisinger Medical Center, and Drexel University School of Medicine. Dr. McCarter has extensive experience defending hospitals and health systems when under scrutiny by the Office of the Inspector General (OIG) and Department of Justice (DOJ).
Jerilyn P. Morrissey, MD
Vice President, Client Performance and Revenue Integrity
Dr. Jerilyn Morrissey is responsible for regulatory, private payer, and utilization management education for case management staff and physicians. Dr. Morrissey is passionate about using data and technology to help hospitals navigate complex Medicare regulations and understand payer practices and their impact on the hospital revenue cycle. Dr. Morrissey’s experience as a practicing physician, a Physician Advisor for a nationally recognized health system, and as a Director of Clinical Information for a national payer, afford her a unique perspective to solve utilization management’s evolving challenges.
Dr. Morrissey received a Bachelor of Arts in Biology from the Illinois Wesleyan University and her medical degree from the University of Illinois. Dr. Morrissey is currently a licensed physician in California.
Joseph R. Zebrowitz, MD
Dr. Joseph R. Zebrowitz is Founder and President of Versalus Health and has led the team in the development of an innovative approach to Two-Midnight Rule compliance. Prior to Versalus, he was Managing Partner of Devon Hill Capital Partners (DHCP), where he led the investment in several successful healthcare startups. Prior to DHCP, Dr. Zebrowitz spent 12 years as Executive Vice President and Senior Medical Director of Executive Health Resources (EHR), where he led the development of EHR’s compliance and revenue integrity products. Dr. Zebrowitz’s career focus has been on assisting hospitals in gaining a true picture of their compliance profiles through analysis and audit and advancing lasting solutions to provide enduring compliance and visibility. Prior to joining EHR, Dr. Zebrowitz founded Concuity, Inc. (formerly eHealthContracts), now part of the Advisory Board Company and served as its Vice President of Strategic Alliances.
Dr. Zebrowitz received his medical degree from Temple University School of Medicine and a bachelor’s degree in psychology from the University of Pennsylvania. He attended the Wharton School of Business at the University of Pennsylvania.
Angela Sorbelli, J.D., LL.M, MBA, CHC
Vice President Regulatory Affairs
Ms. Angela Sorbelli is a consummate compliance professional, with over fifteen years of experience assisting hospitals and health systems navigate the complexities of regulations and compliance. At Versalus, Ms. Sorbelli leads the operational response to regulatory and appeals issues. Prior to joining Versalus, Ms. Sorbelli served as a Director of Healthcare Compliance for a CMS contracted recovery auditor and as a Director of Regulatory Affairs at a large health care solutions company. In both organizations, Ms. Sorbelli had oversight of compliance and regulatory curriculum, and has a proven track record of identifying areas of compliance vulnerability and risk and implementing successful corrective action plans.
Ms. Sorbelli holds an MBA in Healthcare from the University of St. Thomas Opus School of Business and both a J.D. and LL.M in Health Law from Widener University School of Law.